US2005154211A1PendingUtilityA1
Large scale synthesis of 1,2,4- and 1,3,4- oxadiazole carboxylates
Priority: Mar 19, 2002Filed: Dec 14, 2004Published: Jul 14, 2005
Est. expiryMar 19, 2022(expired)· nominal 20-yr term from priority
C07D 271/10C07D 271/06
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are efficient and scalable processes for preparing 1,2,4- and 1,3,4-oxadiazole carboxylates from readily available starting materials.
Claims
exact text as granted — not AI-modified1 . A method for preparing a 1,3,4-oxadiazole carboxylate comprising:
A) reacting the N-protected acylhydrazide with a chloro-oxo-acetic acid ester in the presence of a first base to afford an N-protected diacylhydrazide; B) cyclizing the N-protected diacylhydrazide in the presence of a phosphorous reagent, a per-halogenated methane and a second base to afford the N-protected 1,3,4-oxadiazole; C) deprotecting the N-protected 1,3,4-oxadiazole to form the product.
2 . A method according to claim 1 , wherein the 1,3,4-oxadiazole is
wherein
z is 1 to 6;
each R 4 is independently selected from hydrogen, a suitably protected amino acid residue, or heterocycloalkyl optionally substituted with C 1 -C 6 alkyl, or
C 1 -C 6 alkyl optionally substituted with one or two groups independently selected from thioalkyl, hydroxy, C 1 -C 6 alkoxy, carboxamido, mono or di(C 1 -C 6 alkyl)carboxamido, heterocycloalkyl, amidinyl, mono or di(C 1 -C 6 )amino, protected amino, protected carboxyl, and phenyl, optionally substituted with one or two groups independently selected from C 1 -C 6 alkoxy and C 1 -C 6 alkyl;
R 5 is C 1 -C 6 alkyl or arylalkyl, where each aryl is optionally substituted with one, two or three groups independently selected from C 1 -C 6 alkyl, C 1 -C 6 alkoxy, halogen, nitro, trifluoromethyl, and trifluoromethoxy; and
R 6 is a suitable amino acid protecting group.
3 . A method according to claim 1 wherein the tertiary-butoxycarbonyl protected-amino acid is selected from N-tertiary-butoxycarbonyl glycine, N-tertiary-butoxycarbonyl alanine, N-tertiary-butoxycarbonyl valine, N-tertiary-butoxycarbonyl leucine, N-tertiary-butoxycarbonyl methionine, N-tertiary-butoxycarbonyl isoleucine, N-tertiary-butoxycarbonyl serine, N-tertiary-butoxycarbonyl threonine, N-tertiary-butoxycarbonyl cysteine, N-tertiary-butoxycarbonyl proline, N-tertiary-butoxycarbonyl asparagine, N-tertiary-butoxycarbonyl glutamine, N-tertiary-butoxycarbonyl phenylalanine, N-tertiary-butoxycarbonyl tyrosine, N-tertiary-butoxycarbonyl tryptophan, N-tertiary-butoxycarbonyl lysine, N-tertiary-butoxycarbonyl arginine, N-tertiary-butoxycarbonyl histidine, N-tertiary-butoxycarbonyl aspartine, and N-tertiary-butoxycarbonyl glutamine,
wherein if the protected-amino acid has further reactive sidechains, such sidechains are protected with a suitable protecting group.
4 . A method according to claim 1 wherein the first base is selected from sodium bicarbonate, sodium carbonate, potassium carbonate, calcium carbonate, barium carbonate, cesium carbonate, and strontium carbonate.
5 . A method according to claim 4 wherein the first base is sodium bicarbonate.
6 . A method according to claim 1 wherein R5 is a C 1 -C 4 alkyl group.
7 . A method according to claim 6 wherein the C 1 -C 6 alkyl group is ethyl.
8 . A method according to claim 1 wherein the N-protected acylhydrazide is treated with a chloro-oxo-acetic acid ester in the presence of at least one solvent.
9 . A method according to claim 8 wherein the solvent is aprotic.
10 . A method according to claim 9 wherein the solvent is tetrahydrofuran.
11 . A method according to claim 1 wherein the diacylhydrazide is formed at temperatures between −10° C. and 40° C.
12 . A method according to claim 1 wherein the cyclization of the N-protected diacylhydrazide is performed in the presence of at least one solvent.
13 . A method according to claim 12 wherein the solvent is a halogenated hydrocarbon.
14 . A method according to claim 13 wherein the solvent is dichloromethane.
15 . A method according to claim 1 wherein the second base is selected from triethylamine, diisopropylethylamine, pyridine, and lutidine.
16 . A method according to claim 15 wherein the second base is triethylamine.
17 . A method according to claim 1 wherein the dehydrating agent is a phosphorous reagent combined with a perhalogenated methane.
18 . A method according to claim 17 wherein the phosphorous reagent is triphenylphosphine and the perhalogenated methane is carbon tetrachloride.
19 . A method according to claim 1 wherein the dehydration is performed at temperature of about 15° C. to about 90° C.
20 . A method according to claim 1 wherein the N-protected 1,3,4-oxadiazole is deprotected using a protic reagent.
21 . A method according to claim 20 wherein the protic reagent is hydrogen chloride gas.
22 . A method according to claim 20 wherein the protic reagent is hydrogen chloride gas dissolved in 1,4-dioxane.
23 . A method according to claim 1 wherein the N-protected 1,3,4-oxadiazole is deprotected in the presence of at least one solvent.
24 . A method according to claim 23 wherein the solvent is aprotic.
25 . A method according to claim 24 wherein the solvent is ethyl acetate.
26 . A method according to claim 25 wherein the deprotection is performed at temperature of about −10° C. to about 15° C.
27 . A method according to claim 20 wherein the deprotection is performed without the addition of any additional solvent.
28 . A method according to claim 27 wherein the deprotection is performed at temperature of about −10° C. to about 30° C.
29 . A method for preparing compounds of the formula:
wherein
z is 1 to 6;
each R 4 is independently selected from hydrogen, a suitably protected amino acid residue, or heterocycloalkyl optionally substituted with C 1 -C 6 alkyl, or
C 1 -C 6 alkyl optionally substituted with one or two groups independently selected from thioalkyl, hydroxy, C 1 -C 6 alkoxy, carboxamido, mono or di(C 1 -C 6 alkyl)carboxamido, heterocycloalkyl, amidinyl, mono or di(C 1 -C 6 )amino, protected amino, protected carboxyl, and
phenyl, optionally substituted with one or two groups independently selected from C 1 -C 6 alkoxy and C 1 -C 6 alkyl;
R 5 is C 1 -C 6 alkyl or arylalkyl, where each aryl is optionally substituted with one, two or three groups independenly selected from C 1 -C 6 alkyl, C 1 -C 6 alkoxy, halogen, nitro, trifluoromethyl, and trifluoromethoxy; and
R 6 is a suitable amino acid protecting group; the method comprising
A) reacting an intermediate of the structure
wherein z, R 4 and R 6 are defined above, with
in the presence of a first base and isolating a diacylhydrazide intermediate of the formula:
wherein z, R 4 , R 5 , and R 6 are defined above;
B) cyclizing the diacylhydrazide intermediate in the presence of a phosphorous reagent, a per-halogenated methane and a second base to afford an intermediate of the formula:
wherein z, R 4 , R 5 , and R 6 are defined above;
C) deprotecting the cyclized intermediate to form a compound of the formula:
30 . A method according to claim 29 wherein the phosphorous reagent is triphenylphosphine and the perhalogenated methane is carbon tetrachloride.
31 . A method according to claim 29 wherein R 6 is tertiary-butoxy carbonyl.
32 . A method according to claim 29 wherein R 5 is C 1 -C 6 alkyl.Join the waitlist — get patent alerts
Track US2005154211A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.